PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsScientists breed 'mighty mouse'

BioNews

Scientists breed 'mighty mouse'

Published 9 June 2009 posted in News and appears in BioNews 432

Author

Ailsa Stevens

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Last week the papers were flooded with reports of a so-called 'mighty mouse' - a genetically engineered mouse able to run for up to six hours at a speed of 20 metres per minute before needing a rest - created by researchers based at Case Western Reserve University in...

Last week the papers were flooded with reports of a so-called 'mighty mouse' - a genetically engineered mouse able to run for up to six hours at a speed of 20 metres per minute before needing a rest - created by researchers based at Case Western Reserve University in Cleveland, Ohio. The research, published in the Journal of Biological Chemistry, will help scientists to gain a better understanding of the genes involved in metabolism and muscle strength in humans, potentially leading to new treatments for muscle wasting disorders like Duchene Muscular Dystrophy.


Professor Richard Hanson, who co-led the study, said that the special 'athletic' abilities of the mice are to do with the remarkable way in which they metabolise glucose in the blood. 'They are metabolically similar to Lance Armstrong biking up the Pyrenees; they utilize mainly fatty acids for energy and produce very little lactic acid', he said.


The researchers found that the mice also had other remarkable traits: although the new mice ate 60 per cent more, they were fitter and leaner than normal 'wild-type' mice and they had the ability to give birth at three years old - the equivalent of an 80 year old woman giving birth.


The new mice have been genetically engineered to express a glucose metabolising gene - PEPCK-C - to be over-expressed in the skeletal muscle, allowing them to avoid the muscle-cramping build-up of lactic acid which normal mice, and humans, experience during prolonged exercise.


The research has raised concerns that some athletes might resort to gene therapy to improve their performance, however Professor Hanson argues that this is unlikely. 'We humans have exactly the same gene. But this is not something you would do in a human. It's completely wrong. We do not think that this mouse model is an appropriate model for human gene therapy. It is currently not possible to introduce genes into the skeletal muscles of humans and it would not be ethical to even try'.


In future, the researchers plan to use the new mouse to study the effects of diet and exercise on longevity and cancer risk and potentially to better understand the genetic basis of inherited conditions which lead to muscle wasting in humans.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 February 2010 • 2 minutes read

Scientists set to tackle gene-doping in sport

by Dr Sophie Pryor

Researchers have expressed concern about athlete's use of genetic tools in the 'next generation' of illegal doping, and have stressed the importance of developing reliable new detection tests to stop them. Writing in the journal Science, Theodore Friedmann and colleagues at the University of California warn that 'the time is right to look at how advances in genetics are affecting sport'. The authors highlight the dangers of using imperfect and 'highly risky' genetic techniques, which may have...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 November 2009 • 2 minutes read

Gene therapy for muscle wasting conditions shows promise

by Alison Cranage

Research published in the journal Science Translational Medicine last week shows gene therapy can improve muscle size and strength in monkeys. The technique holds promise as a therapy for several neuromuscular disorders, and researchers hope that clinical trials will start next year....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« UK surrogacy case decided in favour of father

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

27 June 2022 • 2 minutes read

UK report reveals public attitudes to fertility, genomics and embryo research

27 June 2022 • 2 minutes read

Shortage of sperm donors despite men willing to donate

27 June 2022 • 2 minutes read

North East London CCG proposes offering three funded IVF cycles

27 June 2022 • 2 minutes read

Fibrosis drugs reverse ovarian ageing in mice

27 June 2022 • 2 minutes read

Gene implicated in motor neurone diseases discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856